Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania - Test2 - elhamkhani - TriplyDB

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania

http://www.wikidata.org/entity/Q28475232

about

Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review Artemisinin-Based Combination Therapy Versus Quinine or Other Combinations for Treatment of Uncomplicated Plasmodium falciparum Malaria in the Second and Third Trimester of Pregnancy: A Systematic Review and Meta-Analysis The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidence Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China Pregnant women are a reservoir of malaria transmission in Blantyre, Malawi.Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali Parasitologic Assessment of Two-Dose and Monthly Intermittent Preventive Treatment of Malaria during Pregnancy with Sulphadoxine-Pyrimethamine (IPTP-SP) in Lagos, Nigeria Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35 The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis.Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin Monitoring antifolate resistance in intermittent preventive therapy for malaria.Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy.Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients.Novel anti-malarial combinations and their toxicity.Evolution from double to triple-antimalarial drug combinations.Treatment regimens for pregnant women with falciparum malaria.A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.Dihydroartemisinin-piperaquine versus artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana: an open-label, randomised, non-inferiority trial.Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review.Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges.Malaria in pregnancy Which drug is effective and safe for acute malaria in pregnancy? Reviewing the evidence

P2860

Q21133667-8E73BAC2-56B2-4DB1-BE98-0BE04D7C382A Q26770713-2A9A1EFC-062F-4D91-91C7-F78EBECA16CC Q28079877-A012965B-51A7-4357-820E-A6744EA14B72 Q28125914-E304F04B-2548-4575-8EA5-A533F2197F08 Q34425614-2B980863-6190-4A5C-842E-B47C0674AFEF Q34433106-8B982BAE-303E-49F9-BF15-C18AE9E2CC8D Q34456393-3C374DAB-941F-4B16-AC3D-51C20F136006 Q34922481-9C1C86AB-4EDC-4C67-BE29-4BFDC6697CBB Q34993578-4A2A72F9-592C-4020-8542-2565A54420E1 Q35191473-67414753-97CF-43A0-9449-7364D1E05424 Q35398338-03F26BB7-3C4F-46BC-8D8C-04CEF503C19B Q35692279-221F1DB3-83A2-4898-8ED8-DAB1A66C6FE6 Q35805015-453F49E3-50DF-4A4F-9FB9-1774D63F4CE0 Q36178611-5A6036FD-D0D8-40EF-988A-08FE215A1D37 Q36185610-BD99296C-87F0-4E0A-88A8-D0FC4E9F981B Q36368036-D131DCC3-EEF4-4383-A1B1-ECC18A3FFCB4 Q36940415-2F424D3E-A35C-48CE-B899-1BA3655C6525 Q37260585-24FEDD31-6236-4F2F-812C-17363A1899CB Q37735182-4649EE05-0C9C-44D7-9E8E-9791C53E33A3 Q37962462-334D5F4B-DC8B-4E3F-BC85-54D27251F493 Q38203334-3BE13A0D-9BDA-4DCC-BCB7-2F423C1F6E19 Q38303998-F9A1D7B7-9EDF-4C78-8FD7-F2FF60B9DD30 Q38870452-300F130D-CE2B-4CC2-BA7B-192F9909CC9F Q39186451-3F081714-CAC3-4F57-9338-CA1A353AE7AA Q39327919-F41038A8-A4DF-497B-874B-043B1AEB5D89 Q40600918-5889DA5D-ADFB-40F0-A9F5-1FB7890D7F5A Q42712939-11E16179-F9B0-42B0-80DE-F1BADA98A796 Q47158581-F790A399-1A98-4C3D-BC85-052B01F7A5BA Q47244112-590EF366-170D-406B-98ED-6571EADA8081 Q56421802-9047B9A3-2458-442B-A4FA-6C3EF67A1DF9 Q57013833-A73EFE09-20E7-4640-9EA3-57E3E74AEB88

P2860

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania

http://www.wikidata.org/entity/Q28475232

description

2009 nî lūn-bûn

@nan

2009 թուականին հրատարակուած գիտական յօդուած

@hyw

2009 թվականին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@ast

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@en

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@nl

type

label

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@ast

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@en

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@nl

prefLabel

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@ast

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@en

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@nl

P1433

Q28475232-2B8F91D8-1A44-4E65-BA24-CF2EB0CDA395

P1476

Q28475232-32329A75-05A1-486A-B883-6A2E7F11F7A8

P2093

Q28475232-00FEFF2C-C627-482D-ACC4-F3D75C468BCB

Q28475232-16AA3144-3278-4B83-BD13-3B5F7DA631D0

Q28475232-A640CADC-19A0-4B9A-8300-72E13BA34EBB

Q28475232-D91E21F8-098A-467B-866F-81A33DC1A77F

Q28475232-D940B891-840C-4324-9B7C-5933AC92765F

P2860

Q28475232-07B9E5B6-0968-4D29-B684-FED43B5FBED0

Q28475232-2018C804-8932-4696-8318-743FB56990CE

Q28475232-35585364-471E-4844-9896-39D8CD377EDE

Q28475232-368FDBC7-23BA-40D4-A998-52835CDFC1F1

Q28475232-3E0B7A2F-FE0F-4D6A-9E81-E736D88DC0A0

Q28475232-3EF448FF-4B65-45F2-824C-CC1D932A70B7

Q28475232-4AE91FDC-9FE6-4364-849E-5B4827C22BC3

Q28475232-4C0677C8-ED41-431A-B77F-A6989D57032A

Q28475232-4FE15160-4968-4685-830C-448693B27664

Q28475232-540439E8-79EA-45AA-A1AC-8C5E7EB1D185

P304

Q28475232-17A774B3-DB6D-4CD0-9CC7-3BAC67BDC0AD

P31

Q28475232-CD05F8F7-921A-4C63-AD51-683B2E4141BA

P3181

Q28475232-F88FC30A-E748-497A-A5C4-86255BCBB183

P356

Q28475232-D6919A5D-A8B3-4B1A-8C54-7554BEC88A2C

P407

Q28475232-95E8F8C4-1B39-4E1F-8FE6-AA25B367A684

P433

Q28475232-DA974151-BE23-4C30-812A-51E9B9D3A2AE

P478

Q28475232-C82494D0-AC23-4D47-9B12-F2DE7BA4B3E9

P50

Q28475232-287048CB-D330-47C7-A74A-EF8E8D14A548

Q28475232-66266BAA-0B01-44D8-9C9F-B4235CF03633

P577

Q28475232-C2A43CF5-7D5C-4B35-95D7-2EC2542F11FE

P5875

Q28475232-65F9EF19-2F62-4165-A20D-5380337A55EE

P698

Q28475232-B8E52AB8-48DA-453D-9420-A2BEA4A47231

P921

Q28475232-0B2777A4-4618-464C-A0EF-11DDE5D1A656

Q28475232-22878B65-AC51-4AC3-9C13-06D341A01EBE

Q28475232-2D75C112-B079-46BD-9F24-F6B0C0A35CD8

Q28475232-75391FAA-E1CA-4251-83BC-D24F8E135F32

Q28475232-8EFBC6AC-EEFB-4C34-8829-55A9399E6D7F

Q28475232-FC4CF893-29DB-4B30-BF96-EEE2356F46F0

P932

Q28475232-1F6A69BD-F702-438B-9177-579F0FF12062

P3181

P356

JOURNAL.PONE.0005138

P1433

P1476

Randomized trial of artesunate ...... laria in pregnancy in Tanzania

@en

P2093

Brian M Greenwood

http://www.w3.org/2001/XMLSchema#string

Kandi Muze

http://www.w3.org/2001/XMLSchema#string

Marnie Briceño

http://www.w3.org/2001/XMLSchema#string

Rosalynn Ord

http://www.w3.org/2001/XMLSchema#string

Theonest K Mutabingwa

http://www.w3.org/2001/XMLSchema#string

P2860

Drugs for preventing malaria in pregnant women

Chlorproguanil-dapsone for treating uncomplicated malaria

The safety of artemisinins during pregnancy: a pressing question

The safety of amodiaquine use in pregnant women

Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.

Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya.

Detection and clinical manifestation of placental malaria in southern Ghana.

Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?

Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.

HIV and malaria: interactions and implications.

P304

e5138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2636282

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0005138

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Chris J Drakeley

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24263411

http://www.w3.org/2001/XMLSchema#string

P698

19352498

http://www.w3.org/2001/XMLSchema#string

P921

pregnancy-associated malaria

P932

2662423

http://www.w3.org/2001/XMLSchema#string